NCT01753245View on ClinicalTrials.gov

Analysis Of The Influence Of Metabolic Syndrome On Treatment Efficacy With Anti-Tnf In Moderate-Severe Psoriasis In Real Clinical Practice.

UnknownOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

June 30, 2014

Conditions
Psoriasis VulgarisMetabolic Syndrome
Trial Locations (1)

14004

Department of Dermatology. Reina Sofia University Hospital., Córdoba

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Juan Ruano

OTHER_GOV